(Q46880527)

English

Addressing the health technology assessment of biosimilar pharmaceuticals

scientific article published in September 2010

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

editorial

0 references

title

Addressing the health technology assessment of biosimilar pharmaceuticals (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

author

Jonathan Belsey

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

author name string

Alan Stewart

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

Philip Aubrey

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

language of work or name

English

0 references

publication date

1 September 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

published in

Current Medical Research and Opinion

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

volume

26

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

page(s)

2119-2126

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

Identifiers

DOI

10.1185/03007995.2010.505137

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

PubMed publication ID

20649394

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20649394

retrieved

26 December 2017

reference URL

http://europepmc.org/abstract/MED/20649394

(Q46880527)

Addressing the health technology assessment of biosimilar pharmaceuticals

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)